American Brain Tumor Association’s Annual Patient and Family Conference to Address Physical and Cognitive Symptoms and Side Effects

  • SHARE
Printer Friendly

July 25, 2017

CHICAGO, IL – Brain tumor survivors are at significant risk of experiencing losses in physical strength, cognition and mobility due to the tumor itself and the treatments used to control tumor growth. These symptoms often impact the patient’s quality of life as they can put limitations on their ability to maintain autonomy and independent living including driving, returning to work, pursuing leisure activities and engaging in everyday social interactions. Interventions for mitigating fatigue, sleep disturbances, mood swings, cognitive deficits (attention, working memory and processing efficiency), headaches and seizures will be the focus of several sessions planned for the American Brain Tumor Association’s (ABTA) Annual Patient and Family Conference, Redefining Survivorship through Science, Technology and Clinical Innovation being held at The Westin O’Hare in Rosemont, Ill. on August 4-5.  

“Patients and their families are too often unprepared, overwhelmed and ill-equipped to navigate the myriad physical and cognitive symptoms and side effects brought on by their tumor and tumor treatments,” said Elizabeth M. Wilson, ABTA president and CEO. “This year’s conference brings together several experts in both pediatric and adult brain tumor symptom management to provide attendees with information on current approaches and new research efforts in restoring physical and cognitive functioning that have been shown to improve quality of life and overall survivorship.”

Morning panel presentations on day two of the conference feature topics on “Engaging Patients in Research” including:


Computerized Cognitive Training: Brain Games & Brain Training

Heather Conklin, PhD, St. Jude Children’s Hospital

The International Low Grade Glioma Registry
Elizabeth Claus, MD, PhD, Brigham and Women’s Hospital and Yale School of Public Health

Meningiomas and Fatigue
Gelareh Zadeh, MD, PhD, FRCSC, Princess Margaret Cancer Centre, Toronto    


Breakout sessions addressing symptom management and treatment side effects include:


Altering Metabolism for Brain Tumor Therapy: Food for Thought

Adrienne Scheck, PhD, Barrow Neurological Institute
Leonora Renda, MS, RDN, Dignity Health

Depression & Mood Swings
Debra Kangisser, PA-C, Cleveland Clinic

Brain Tumor in Adults & Rehabilitation
Rajesh R. Yadav, MD, The University of Texas MD Anderson Cancer Center

Seizure Management in Neuro-Oncology
Rima Lukas, MD, Northwestern University  


The ABTA National Patient & Family Conference, Redefining Survivorship through Science, Technology and Clinical Innovation is being held at The Westin O’Hare in Rosemont, Ill., August 4-5. Advance registration is encouraged; walk-in registration will be based upon space availability.  

To view the conference program and register, visit www.braintumorconference.org, or call 800-886-ABTA (2282) or email info@abta.org.

###

Media Contact:
Rachael Goniu
773-577-8792
rgoniu@abta.org